Ziprasidone clinical trials
Also written Geodon and Zeldox.
How each study uses ziprasidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 5 Feb 2001 · GEODON · NDA 020825 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
96 studies that test it; most in 2003 (16)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 16 |
| 2004 | 10 |
| 2005 | 7 |
| 2006 | 16 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 40 · Other 57
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (36) · Massachusetts General Hospital (4) · The University of Texas Health Science Center at San Antonio (3) · Fundación Marques de Valdecilla (3) · Duke University (3) · Washington University School of Medicine (2) · Tufts Medical Center (2) · Dr. Reddy's Laboratories Limited (2)
Often tested with
Tested in the same studies.
Olanzapine (15) · Quetiapine (11) · Aripiprazole (11) · Risperidone (10) · Haloperidol (6) · Amisulpride (3) · Perphenazine (2) · Sulpiride (2)
Related medicines
As reviewed, each with the page that says it.
- One of Antipsychotics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test ziprasidone.
- Feb 2027Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaPhase 1 · University of Arizona
Studies
Open first, then newest update. How each study uses ziprasidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 97
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaActive, not recruitingPhase 1University of ArizonaNCT03781115Written as Ziprasidone
- Switching Medication to Treat SchizophreniaCompletedPhase 4Icahn School of Medicine at Mount SinaiNCT00044655Written as Ziprasidone
- Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTerminatedPhase 3Northwestern UniversityNCT00288353Written as ziprasidone (Geodon)
- Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)CompletedPhase 4VA Palo Alto Health Care SystemNCT01172652Written as Ziprasidone
- Ziprasidone in Early Onset Schizophrenia Spectrum DisordersCompletedPhase 2University of North Carolina, Chapel HillNCT01006551Written as Ziprasidone
- Ziprasidone in the Psychosis ProdromeCompletedPhase 2Yale UniversityNCT00635700Written as ziprasidone
- Reducing the Abuse of Opioids in Drug UsersTerminatedEarly Phase 1The University of Texas Health Science Center at San AntonioNCT03837860Written as Oxycodone/Ziprasidone
- Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I DisorderTerminatedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT03768726Written as Ziprasidone
- Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderTerminatedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT02075047Written as ziprasidone oral capsules
- 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic SubjectsCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00312494Written as Ziprasidone
- A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.CompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00282464Written as Geodon (Ziprasidone)
- Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00406315Written as ziprasidone
- Ziprasidone And Olanzapine's Outcomes In ManiaTerminatedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00329108Written as ziprasidone hydrochloride
- Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)CompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00280566Written as Ziprasidone Oral Capsule
- Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00265330Written as Ziprasidone oral capsules
- A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I DepressionCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00141271Written as Geodon (Ziprasidone)
- Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaTerminatedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00257192Written as Ziprasidone oral capsules
- Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031CompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00174447Written as Ziprasidone
- Adjunctive Ziprasidone in the Treatment of Bipolar I DepressionCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00483548Written as Ziprasidone
- Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00257166Written as Ziprasidone oral capsules
See all 97 studies that test ziprasidone →
Given beside what is tested · 5 — ziprasidone is usual care or a partner of the new treatment
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic MedicationCompletedPhase 2Astellas Pharma Global Development, Inc.NCT03557931Written as ziprasidone
- Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With SchizophreniaCompletedPhase 2Georgetown UniversityNCT00509067Written as risperidone, olanzapine, quetiapine, ziprasidone, and/or aripiprazole
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia SymptomsCompletedPhase 3Donald C. Goff, MDNCT00403546Written as Ziprasidone 80-160 mg/d
- Tandospirone Combined With Atypical Antipsychotic Drugs in SchizophreniaStatus unknownPhase 4Qingyun YinNCT02040883Written as Risperidone/Olanzapine/Quetiapine/Ziprasidone/Aripiprazole
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic SettingCompletedPhase 4University of BergenNCT00932529Written as Ziprasidone
As the comparator · 4 — what is tested is compared with ziprasidone
- Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaCompletedPhase 3Vanda PharmaceuticalsNCT00254202Written as Ziprasidone
- Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial CapsulesCompletedPhase 1Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00821444Written as ziprasidone
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyCompletedPhase 4Northwell HealthNCT00330863Written as Ziprasidone
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for SchizophreniaCompletedNot applicableBeijing HuiLongGuan HospitalNCT02192723Written as Ziprasidone
Codes
What other systems call ziprasidone · ClinicalTrials.gg INT003831
- MeSH (NLM) C092292ziprasidoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6UKA5VEJ6XZIPRASIDONEConfirmed FDA, NLM, Wikidata
- RxNorm 115698Confirmed FDA, Wikidata
- Wikidata Q205517ziprasidoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47788ZiprasidoneOne source FDA
- DrugBank DB00246One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C092292 | ziprasidone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6UKA5VEJ6X | ZIPRASIDONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 115698 | — | Confirmed FDA, Wikidata |
| Wikidata | Q205517 | ziprasidone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47788 | Ziprasidone | One source FDA |
| DrugBank | DB00246 | — | One source Wikidata |
Also registered as ziprasidone hydrochloride (UNII 216X081ORU · RxNorm 284925).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.